31
Views
12
CrossRef citations to date
0
Altmetric
Research Article

TWO-WEEK AEROSOL INHALATION STUDY IN RATS OF ETHYLENE OXIDE/PROPYLENE OXIDE COPOLYMERS

, , &
Pages 15-31 | Published online: 27 Sep 2008
 

ABSTRACT

Previous studies have shown that aerosols of an ethylene oxide/ propylene oxide copolymer (UCON® 50-HB-5100) produced an inflammatory response in lungs of rats in short-term repeated exposures at relatively low concentrations. This study was carried out on related polyalkylene glycols (EO/PO copolymers) to determine if similar effects would occur upon short-term repeated exposure. Rats were treated by whole body liquid droplet aerosol exposures of six hours per day, five days per week for two consecutive weeks to each of five EO/PO copolymers. The exposure level for the positive control (UCON® 50-HB-5100) was 55 mg/m3, while the remaining 4 test copolymers were evaluated at 100 mg/m3. Each exposure group consisted of ten male albino rats.

After three exposures, nine of ten rats exposed to UCON® 50-HB-5100, and six of ten rats exposed to UCON® 50-HB-2000 had died. At necropsy, congestion, consolidation and red discoloration of the lungs were noted. A moderate to severe alveolitis, characterized by intraalveolar edema, hemorrhage and fibrin deposition, was observed microscopically. Surviving rats from these two groups were sacrificed after five days of exposure. At necropsy, these rats exhibited elevated lung weights and similar macroscopic and microscopic lesions.

Rats exposed to the other test materials (UCON® 75-H-1400, Pluronic® L17R1, Pluronic® L31, and Pluronic® L64) survived with essentially no signs of toxicity through the ten exposure days. Body weights, organ weights, hematological evaluation, pharmacotoxic signs, and macroscopic and microscopic evaluation after necropsy were similar between groups and when compared to the negative control group. Only a slight alveolitis was noted after two weeks of exposure which subsided by two-weeks post exposure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.